Mycotoxins and Human Health

Total Page:16

File Type:pdf, Size:1020Kb

Mycotoxins and Human Health chapter 6. Mycotoxins and human health Summary especially in vulnerable populations. 1. Introduction For fumonisins, studies indicate a Mycotoxins have been investigated possible role in oesophageal cancer This chapter covers the effects on in relation to a wide range of adverse and in neural tube defects, although human health of the major mycotoxins human health effects, but the evidence no definitive conclusions can be occurring in foods. This chapter also for all but a small number of associations drawn at present. For deoxynivalenol includes information on mechanisms is limited. Thus, the full impact on human and other trichothecenes, exposure of action of mycotoxins in humans CHAPTER 6 CHAPTER health of the widespread exposure has been linked to acute poisoning where relevant to the adverse health to mycotoxins remains to be defined. outbreaks in large numbers of effects under consideration. No The main exception is for aflatoxins; subjects. For ochratoxin A and attempt is made at a comprehensive epidemiological, experimental, and zearalenone, the human health review, but at appropriate points we mechanistic studies have contributed effects remain undefined. The limited refer to more extensive accounts. to establishing aflatoxins as a tools available to accurately assess The major source of human cause of human liver cancer, with a human exposure to mycotoxins and exposure to mycotoxins is consump- particularly elevated risk in people the relative paucity of epidemiological tion of contaminated foods. Exposure chronically infected with hepatitis B studies need to be addressed if the full is highest when those foods are dietary virus. In addition, acute aflatoxicosis extent of the adverse effects of these staples, such as maize, groundnuts, or after exposure to high dietary toxin common dietary contaminants is to be various other cereals. Exposures to levels has been demonstrated. The understood and adequate public health metabolites or parent toxins may also impairment of child growth by aflatoxin measures taken. In this respect, newly occur by consumption of contaminated exposure early in life remains an established biomarkers of exposure at milk and milk products. We covered important subject of study. More the individual level are proving valuable the dietary sources of mycotoxin information is also required on the in improving exposure assessment in exposure in some detail in Chapter 1. potential immune effects of aflatoxins, epidemiological studies. In this chapter, we also consider Chapter 6. Mycotoxins and human health 87 occupational exposures in granaries 2. Aflatoxins but is less mutagenic than AFB1, and other food and feed processing reflecting the stearic chemistry of the due to mycotoxins contained in dusts Aflatoxins are produced in a wide respective epoxides; the AFB1-8,9- from contaminated grains. The specific range of commodities by Aspergillus epoxide intercalates more readily into effects due to particular mycotoxins are flavus and A. parasiticus, and the DNA double helix than does the discussed in Sections 2–6. Additional, occasionally other Aspergillus species. equivalent AFG1 molecule, resulting in more general information on health The commodities most at risk are higher levels of DNA adduct formation problems associated with mycotoxins maize and groundnuts in tropical areas for a given dose. Minimal information in grain dusts is covered in Section 7. (see Chapter 1). exists about the importance of The human health effects the reactive epoxide for the non- considered here encompass acute 2.1 Mechanisms mutagenic actions of aflatoxins or poisoning, cancer, other chronic indeed about the biological effects of diseases, and biological effects, Until recently, attention on af- aflatoxins independent of metabolic including growth impairment and latoxins has been focused on activation to the 8,9-epoxide. Unlike immunomodulation. their carcinogenic effects. For AFM2, AFM1 contains an 8,9 double One of the major limitations more detailed information, see the bond and hence can be bioactivated in assessing the effects of extensive reviews in IARC (2002), to the reactive 8,9-epoxide. mycotoxins on health has been WHO (2002), and Wild and Gong A significant observation in the inability to accurately assess (2010). Consideration is usually given terms of aflatoxin carcinogenicity is exposure at the individual level. to the naturally occurring aflatoxins the association between exposure The development of validated in the diet – aflatoxins B1 (AFB1), B2 and a specific mutation in the TP53 biomarkers for aflatoxins has greatly (AFB2), G1 (AFG1), and G2 (AFG2) – tumour suppressor gene in liver assisted epidemiological studies and or to AFB1 alone, or more rarely to cancer (hepatocellular carcinoma allowed an evaluation of aflatoxins aflatoxins M1 (AFM1) and M2 (AFM2), [HCC]). In HCC tumours from patients in relation to cancer, aflatoxicosis, the hydroxylation products of AFB1 who are from regions endemic for child growth impairment, and immune and AFB2, respectively, that occur aflatoxin and who are chronically effects (see Wild and Gong, 2010). in milk. This distinction between the infected with hepatitis B virus (HBV), Development of validated biomarkers type of aflatoxin exposures under a high prevalence exists of a specific for fumonisins (Wild and Gong, 2010; consideration is important but is missense mutation in the gene, Van der Westhuizen et al., 2011) rarely considered, particularly when namely an AGG → AGT (Arg → Ser) and deoxynivalenol (Meky et al., studying adverse health effects other point mutation at codon 249 (codon 2003; Turner et al., 2008a, 2008b, than cancer. 249ser) (IARC, 2002; Hussain et al., 2008c) also offers promise for future Given the focus on mutagenicity 2007). This mutation is extremely rare studies of the human health effects and carcinogenicity, most studies in HCC associated with HBV in areas of these mycotoxins. However, have been of AFB1, which, due to the where aflatoxins are uncommon, the biomarker field for mycotoxins presence of a double bond at the 8,9 but it is as yet unclear whether HBV also offers a cautionary tale: an position, can be metabolized to the infection influences occurrence of unvalidated biomarker for ochratoxin reactive AFB1-8,9-epoxide, which the mutation in HCC from aflatoxin- A in plasma or serum has been binds to cellular macromolecules endemic areas. used to assess dietary exposure including DNA (for more detail, see The major human cytochrome to this toxin, but subsequent Wild and Turner, 2002). The major P450 (CYP) enzymes involved in careful duplicate diet studies have DNA adduct is AFB1-N7-guanine, and aflatoxin metabolism are CYP3A4, shown that this biomarker does not this pro-mutagenic lesion commonly 3A5, and 1A2, and the predominant reflect intake at the individual level results in a G → T transversion site of bioactivation is the liver, (Gilbert et al., 2001). Nevertheless, mutation. AFB1-N7-guanine can although CYP3A4 expression in the availability of biomarkers to also be detected in the urine and the human intestine means that measure exposure to mycotoxins used as an exposure biomarker in metabolism may also occur in that provides new opportunities for more epidemiological studies. AFB2 and organ (Wild and Turner, 2002; systematic monitoring of exposure AFG2 are generally considered to be Kamdem et al., 2006; Thelen and in populations as well as improved far less biologically active due to the Dressman, 2009). The contribution of etiological studies. absence of the 8,9 double bond. AFG1 these enzymes to AFB1 metabolism in can be bioactivated to the 8,9-epoxide exposed people will depend on both 88 the affinity and level of expression An understanding of the Baumgartner et al., 2005; Lewis et of the different enzymes; CYP3A4 metabolism, DNA damage, and al., 2005). These outbreaks resulted appears to be the most important in induction of mutations in people in several hundred deaths associated generating the exo-8,9-epoxide, and exposed to aflatoxins in the diet with consumption of maize heavily the relative contribution of CYP3A5, has contributed to the overall contaminated with aflatoxin. A case– which also produces the exo-8,9- assessment of their adverse health control study of aflatoxicosis, defined epoxide, varies by individual (Kamdem effects (Groopman et al., 2008; Wild as acute jaundice of unknown origin, et al., 2006). In fact, CYP3A5 and Gong, 2010). The major health found that aflatoxin levels in foods expression is polymorphic and effects linked to aflatoxin exposure from affected households were varies by ethnic group; for example, are described briefly here. much higher than those in foods 40% of African Americans show no from unaffected households. Similar expression due to identified genetic 2.2 Aflatoxicosis differences between cases and polymorphisms. Such polymorphisms controls were found when aflatoxin may affect sensitivity to the toxic Sporadic historical accounts of biomarker levels in blood were effects of aflatoxins (Wojnowski et al., human poisoning with aflatoxins examined (Azziz-Baumgartner et al., 2004). CYP1A2 leads predominantly were reported, but these early 2005; McCoy et al., 2008). to formation of the hydroxylated AFM1 studies were not definitive in The association of aflatoxin metabolite and the AFB1-endo-8,9- assigning causation (Hall and Wild, contamination of maize with acute epoxide, which does not form DNA 1994). In 1974, hepatitis cases due hepatitis and aflatoxicosis is well adducts. to
Recommended publications
  • FOLIA VETERINARIA Is a Scientific Journal Issued by the University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, 041 81 Košice, Slovakia
    FOLIA VETERINARIA The scientific journal of the ISSN 0015-5748 UNIVERSITY OF VETERINARY MEDICINE AND eISSN PHARMACY IN KOŠICE — Slovakia 2453-7837 2 LXIV • 2020 FOLIA VETERINARIA is a scientific journal issued by the University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, 041 81 Košice, Slovakia. The journal is published quaterly in English (numbers 1—4) and distributed worldwide. The list of Editorial Board of scientific journal Folia Veterinaria: Editor-in-Chief: Jana Mojžišová Deputy/Managing Editor: Juraj Pistl Editorial Board: Aland, A. (Tartu, Estonia), Banhazi, T. (Toowomba, Aus- tralia), Bao, E. (Nanjing, China), Bíreš, J. (Bratislava, Slovakia), Celer, V. (Brno, Czechia), Fablet, Ch. (Ploufragan, France), Faix, Š. (Košice, Slovakia), Faixová, Z. (Košice, Slovakia), Fedoročko, P. (Košice, Slovakia), Gunnarsson, S. (Skara, Sweden), Kolacz, R. (Wrocław, Poland), Könyves, L. (Budapest, Hungary), Nagy, J. (Košice, Slovakia), Novák, M. (Bratislava, Slovakia), Paulsen, P. (Vienna, Austria), Pěchová, A. (Brno, Czechia), Sossidou, E. N. (Thermi Thessa- loniki, Greece), Večerek, V. (Brno, Czechia), Vorlová, V. (Brno, Czechia) Vargová, M. — technical editor (Košice, Slovakia) Contact: tel.: +421 915 984 669 e-mail: [email protected] Electronic Publisher: De Gruyter Poland, Bogumila Zuga 32A 01-811 Warsaw, Poland ISSN 2453-7837 on-line ISSN 0015-5748 print EV 3485/09 Publisher’s Identification number: IČO 00397474 June 2020 FOLIA VETERINARIA PUBLISHED BY THE UNIVERSITY OF VETERINARY MEDICINE AND PHARMACY IN KOŠICE SLOVAK IA Folia Veterinaria Vol. 64, 2, 2020 V YDÁVA UNIVERZITA VETERINÁRSKEHO LEKÁRSTVA A FARMÁCIE V KOŠICIACH 2020 F O L I A V E T E R I N A R I A, 64, 2, 2020 C O N T E N T S ADESOKAN, H.
    [Show full text]
  • Evaluation of the Individual and Combined Toxicity of Fumonisin Mycotoxins in Human Gastric Epithelial Cells
    International Journal of Molecular Sciences Article Evaluation of the Individual and Combined Toxicity of Fumonisin Mycotoxins in Human Gastric Epithelial Cells Song Yu, Bingxuan Jia, Na Liu, Dianzhen Yu and Aibo Wu * SIBS-UGENT-SJTU Joint Laboratory of Mycotoxin Research, CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China; [email protected] (S.Y.); [email protected] (B.J.); [email protected] (N.L.); [email protected] (D.Y.) * Correspondence: [email protected]; Tel.: +86-21-54920716 Received: 23 July 2020; Accepted: 14 August 2020; Published: 18 August 2020 Abstract: Fumonisin contaminates food and feed extensively throughout the world, causing chronic and acute toxicity in human and animals. Currently, studies on the toxicology of fumonisins mainly focus on fumonisin B1 (FB1). Considering that FB1, fumonisin B2 (FB2) and fumonisin B3 (FB3) could coexist in food and feed, a study regarding a single toxin, FB1, may not completely reflect the toxicity of fumonisin. The gastrointestinal tract is usually exposed to these dietary toxins. In our study, the human gastric epithelial cell line (GES-1) was used as in vitro model to evaluate the toxicity of fumonisin. Firstly, we found that they could cause a decrease in cell viability, and increase in membrane leakage, cell death and the induction of expression of markers for endoplasmic reticulum (ER) stress. Their toxicity potency rank is FB1 > FB2 >> FB3. The results also showed that the synergistic effect appeared in the combinations of FB1 + FB2 and FB1 + FB3.
    [Show full text]
  • | Hao Wanatha Maria Del Contatta Datum
    |HAO WANATHA MARIAUS009844679B2 DEL CONTATTA DATUM (12 ) United States Patent ( 10 ) Patent No. : US 9 ,844 , 679 B2 Nayfach - Battilana ( 45 ) Date of Patent : * Dec . 19 , 2017 (54 ) NANOPARTICLE - SIZED MAGNETIC (56 ) References Cited ABSORPTION ENHANCERS HAVING THREE - DIMENSIONAL GEOMETRIES U . S . PATENT DOCUMENTS ADAPTED FOR IMPROVED DIAGNOSTICS 4 , 106 ,488 A 8 / 1978 Gordon AND HYPERTHERMIC TREATMENT 4 ,303 ,636 A 12/ 1981 Gordon ( 71 ) Applicant: Qteris, Inc. , San Rafael, CA (US ) ( Continued ) ( 72 ) Inventor : Joseph N . Nayfach - Battilana , San FOREIGN PATENT DOCUMENTS Rafael , CA (US ) EP 0040512 B1 11 / 1981 EP 0136530 A16 /1988 (73 ) Assignee : Qteris, Inc. , San Rafael , CA (US ) (Continued ) ( * ) Notice : Subject to any disclaimer , the term of this patent is extended or adjusted under 35 OTHER PUBLICATIONS U . S . C . 154 ( b ) by 903 days. “ Krishna et al ., Unusual size -dependent magnetization in near This patent is subject to a terminal dis hemispherical Co nanomagnets on SiO . sub . 2 from fast pulsed laser claimer . processing” , J . Appl. Phys. 103 , 073902 (2008 ) (“ Krishna ” ) .* (Continued ) ( 21 ) Appl . No .: 14 /044 , 251 Primary Examiner — Joseph Stoklosa (22 ) Filed : Oct. 2 , 2013 Assistant Examiner — Adam Avigan (74 ) Attorney , Agent, or Firm — Marek Alboszta (65 ) Prior Publication Data US 2014 /0172049 A1 Jun . 19 , 2014 (57 ) ABSTRACT Nanoparticle- sized magnetic absorption enhancers (MAES ) Related U . S . Application Data exhibiting a controlled response to a magnetic field , includ ing a controlled mechanical response and an inductive (62 ) Division of application No . 12 /925 ,904 , filed on Nov. thermal response . The MAEs have a magnetic material that 1 , 2010 , now Pat .
    [Show full text]
  • Rope Parasite” the Rope Parasite Parasites: Nearly Every AuSC Child I Ever Treated Proved to Carry a Significant Parasite Burden
    Au#sm: 2015 Dietrich Klinghardt MD, PhD Infec4ons and Infestaons Chronic Infecons, Infesta#ons and ASD Infec4ons affect us in 3 ways: 1. Immune reac,on against the microbes or their metabolic products Treatment: low dose immunotherapy (LDI, LDA, EPD) 2. Effects of their secreted endo- and exotoxins and metabolic waste Treatment: colon hydrotherapy, sauna, intes4nal binders (Enterosgel, MicroSilica, chlorella, zeolite), detoxificaon with herbs and medical drugs, ac4vaon of detox pathways by solving underlying blocKages (methylaon, etc.) 3. Compe,,on for our micronutrients Treatment: decrease microbial load, consider vitamin/mineral protocol Lyme, Toxins and Epigene#cs • In 2000 I examined 10 au4s4c children with no Known history of Lyme disease (age 3-10), with the IgeneX Western Blot test – aer successful treatment. 5 children were IgM posi4ve, 3 children IgG, 2 children were negave. That is 80% of the children had clinical Lyme disease, none the history of a 4cK bite! • Why is it taking so long for au4sm-literate prac44oners to embrace the fact, that many au4s4c children have contracted Lyme or several co-infec4ons in the womb from an oVen asymptomac mother? Why not become Lyme literate also? • Infec4ons can be treated without the use of an4bio4cs, using liposomal ozonated essen4al oils, herbs, ozone, Rife devices, PEMF, colloidal silver, regular s.c injecons of artesunate, the Klinghardt co-infec4on cocKtail and more. • Symptomac infec4ons and infestaons are almost always the result of a high body burden of glyphosate, mercury and aluminum - against the bacKdrop of epigene4c injuries (epimutaons) suffered in the womb or from our ancestors( trauma, vaccine adjuvants, worK place related lead, aluminum, herbicides etc., electromagne4c radiaon exposures etc.) • Most symptoms are caused by a confused upregulated immune system (molecular mimicry) Toxins from a toxic environment enter our system through damaged boundaries and membranes (gut barrier, blood brain barrier, damaged endothelium, etc.).
    [Show full text]
  • Studies in the Use of Magnetic Microspheres for Immunoaffinity Extraction of Paralytic Shellfish Poisoning Toxins from Shellfish
    Toxins 2011, 3, 1-16; doi:10.3390/toxins3010001 OPEN ACCESS toxins ISSN 2072-6651 www.mdpi.com/journal/toxins Article Studies in the Use of Magnetic Microspheres for Immunoaffinity Extraction of Paralytic Shellfish Poisoning Toxins from Shellfish Raymond Devlin 1, Katrina Campbell 1, Kentaro Kawatsu 2 and Christopher Elliott 1,* 1 Institute of Agri-Food and Land Use, School of Biological Sciences, Queen’s University Belfast, Stranmillis Road, Belfast, BT9 5AG, Northern Ireland, UK; E-Mails: [email protected] (R.D.); [email protected] (K.C.) 2 Division of Bacteriology, Osaka Prefectural Institute of Public Health, Osaka, Japan; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +44-28-9097-6549; Fax: +44-28-9097-6513. Received: 19 November 2010; in revised form: 10 December 2010 / Accepted: 14 December 2010 / Published: 4 January 2011 Abstract: Paralytic shellfish poisoning (PSP) is a potentially fatal human health condition caused by the consumption of shellfish containing high levels of PSP toxins. Toxin extraction from shellfish and from algal cultures for use as standards and analysis by alternative analytical monitoring methods to the mouse bioassay is extensive and laborious. This study investigated whether a selected MAb antibody could be coupled to a novel form of magnetic microsphere (hollow glass magnetic microspheres, brand name Ferrospheres-N) and whether these coated microspheres could be utilized in the extraction of low concentrations of the PSP toxin, STX, from potential extraction buffers and spiked mussel extracts. The feasibility of utilizing a mass of 25 mg of Ferrospheres-N, as a simple extraction procedure for STX from spiked sodium acetate buffer, spiked PBS buffer and spiked mussel extracts was determined.
    [Show full text]
  • Mycotoxins (Ochratoxin A, Citrinin, and Sterigmatocystin ) and Toxigenic Fungi in Grains and Other Agricultural Products
    MYCOTOXINS AND TOXIGENIC FUNGI Mycotoxins (Ochratoxin A, Citrinin, and Sterigmatocystin ) and Toxigenic Fungi in Grains and Other Agricultural Products Peter M. Scott,” Wilhelmina van Walbeek, Barry Kennedy, and Defenser Anyeti Ochratoxin A was detected in 18 out of 29 samples three samples of mixed feeds (one of which contained of heated grain from Saskatchewan farms at con- ochratoxin A), from four samples of dried white centrations of 0.03 to 27 ppm. After development beans (three containing ochratoxin A), and from an of an appropriate screening method, 13 of these ochratoxin A positive sample of moldy peanuts. samples were also found to contain citrinin (0.07 to P. cyclopium Westling that produced penicillic acid 80 ppm). Sterigmatocystin was detected in one was isolated quite frequently, particularly from mixed grain sample. Strains of Penicillium ciridicatum feeds, although the mycotoxin itself was not found in Westling or P. palitans Westling, producing either the samples. Zearalenone was identified in a culture ochratoxin A or citrinin or (usually) both toxins of Fusarium equiseti (Corda) Sacc. isolated from a concomitantly, were isolated from 22 grain samples wheat sample. (including 16 of those containing ochratoxin A), from chratoxin A [(-)-N-[(5-chloro-8-hydroxy-3-methyl-l- [2,3-c]xanthen-7-one], a carcinogenic metabolite of Asper- oxo-7-isochrornanyl)carbonyl]-3-phenylalanine~, one gillus cersicolor, A. nidulans, A. rugulosus, P. luteum, and 0 of six closely related metabolites (Steyn and Holzapfel, a Bipolaris sp. (Ballantine et ai., 1965; Dean, 1963; Holzap- 1967), was first isolated from a strain of Aspergillus ochraceus fel et ai., 1966; Purchase and van der Watt, 1970), were also Wilh.
    [Show full text]
  • Assessment of Dietary Intake of Ochratoxin a by the Population of EU Member States
    Reports on tasks for scientific cooperation Report of experts participating in Task 3.2.7 January 2002 Assessment of dietary intake of Ochratoxin A by the population of EU Member States Directorate-General Health and Consumer Protection 1 TASK 3.2.7 "ASSESSMENT OF DIETARY INTAKE OF OCHRATOXIN A BY THE POPULATION OF EU MEMBER STATES" Co-ordinators: Marina Miraglia and Carlo Brera Istituto Superiore di Sanità – Rome – Italy Collaborators: Barnaba Pazzaglini and Silvana Grossi Istituto Superiore di Sanità – Rome – Italy 2 CONTENTS Foreword……………………………………………………………………………………… Introduction…………………………………………………………………………………… OA Occurrence in food……………………………………………………………………….. Consumption data…………………………………………………………………………….. OA Dietary intake…………………………………………………………………………….. OA Occurrence in biological fluids…………………………………………………………... · Estimate of the OA dietary intake on the basis of OA level in serum/plasma………... · OA level in human milk and estimated dietary intakes for babies…………………… Discussion and Conclusions………………………………………………….…………….… Acknowledgements…………………………………………………………………………… Annex 1 Basic information on Ochratoxin A Annex 2 Timetable Annex 3 Instructions for participants Annex 4 Glossary Annex 5 List of participants Annex 6 References 3 FOREWORD According to Council Directive 93/5/EEC "on the assistance to the Commission and co-operation by the Member States in the scientific examination of questions relating to food" Member States of the European Union can co-operate on problems facing the Commission in the area of food. Directive 93/5/EEC also indicates that an inventory of Tasks to be undertaken has to be published as a Commission Decision at least every six months. For each Task, the participating Member States, the Member State which provides co-ordination and time limit for completion will be indicated. The rationale for each Task is to provide harmonised and reliable information to be used by the Commission for the management of problems related to food.
    [Show full text]
  • Safety Data Sheet - Version 5.0 Preparation Date 6/19/2013 Latest Revision Date (If Revised) 10/3/2016 SDS Expiry Date 10/2/2019
    Safety Data Sheet - Version 5.0 Preparation Date 6/19/2013 Latest Revision Date (If Revised) 10/3/2016 SDS Expiry Date 10/2/2019 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1 Product Identifier Chemical Name Ochratoxin A-d5 Catalogue # O148492 1.2 Relevant Identified Uses of the Substance or Mixture and Uses Advised Against Product Uses To be used only for scientific research and development. Not for use in humans or animals. 1.3 Details of the Supplier of the Safety Data Sheet Company Toronto Research Chemicals 2 Brisbane Road Toronto, ON M3J 2J8 CANADA Telephone +14166659696 FAX +14166654439 Email [email protected] 1.4 Emergency Telephone Number Emergency# +14166659696 between 0800-1700 (GMT-5) 2. HAZARDS IDENTIFICATION WHMIS Classification (Canada) WHMIS Symbols (Canada) D1A Very Toxic Material Causing Immediate and Serious Toxic Effects Toxic by Ingestion D2A Very Toxic Material Causing Other Toxic Effects Reproductive Toxic/Teratogen/Carcinogen D2B Toxic Material Causing Other Toxic Effects Moderate Skin/Eye Irritant Mutagen 2.1/2.2 Classification of the Substance or Mixture and Label Elements GHS Hazards Classification (According to EU Regulation 1272/2008 and US OSHA 1910.1200) Acute Toxicity, Oral (Category 2) Skin Irritation (Category 2) Carcinogenicity (Category 2) Reproductive Toxicity (Category 2) Specific Target Organ Toxicity, Repeated Exposure (Category 2) Hazardous to the Aquatic Environment, Long-Term Hazard (Category 4) EU Classification (According to EU Regulation 67/548/EEC) Very toxic if swallowed. Irritating to the skin. May cause cancer. Possible risk of harm to the unborn child. Possible risk of impaired fertility.
    [Show full text]
  • Cannabis Scientist
    AUGUST 2018 # 05 the Cannabis Scientist Upfront Upfront Feature Sitting Down With Mobile testing hits UK relaxes rules on Who are your cannabis THC trailblazer, Raphael the road medical cannabis scientists of the year? Mechoulam 6 10 20 – 23 26 – 27 Smashing the Grass Ceiling Cannabis – a fresh opportunity for women in science? 12 – 19 www.theanalyticalscientist.com REFINE™ NEW YOUR WORKFLOW UCT'S ALL NEW REFINETM 96 WELLPLATE AND COLUMNS FEATURE A UNIQUE SUBMICRON FRIT COMBINATION FOR EFFECTIVE CANNABIS FILTRATION PRIOR TO LC-MS/MS ANALYSIS UCT. INC • 2731 BARTRAM RD, BRISTOL, PA 19007 • 800.385.3153 • UNITEDCHEM.COM ™ NEW REFINE Contents YOUR WORKFLOW 12 TM 05 Editorial Features 26 UCT'S ALL NEW REFINE 96 WELLPLATE AND COLUMNS The Great Divide, by Charlotte Barker 12 Smashing the Grass Ceiling FEATURE A UNIQUE SUBMICRON FRIT COMBINATION FOR EFFECTIVE Meet seven successful female scientists blazing a trail in the CANNABIS FILTRATION PRIOR TO LC-MS/MS ANALYSIS cannabis industry. Upfront 20 Th e Cannabis Scientists 06 Take the High Road of the Year 2018 The votes are in! Who were 08 Yes We Can(nabis)! your picks for the top cannabis scientists of 2018? 08 Trip Advisor 09 Leaving Them Breathless 24 Application Note 09 An FDA First Sitting Down With 26 Raphael Mechoulam, Professor of Medicinal Chemistry at the Hebrew University of Jerusalem, Israel. UCT. INC • 2731 BARTRAM RD, BRISTOL, PA 19007 • 800.385.3153 • UNITEDCHEM.COM www.theanalyticalscientist.com The Great Divide Editorial If we really want to fill the cannabis research vacuum, we need to disentangle the science from the politics.
    [Show full text]
  • Methodological Approach to Developing a Risk-Ranking Model for Food Tracing FSMA Section 204 (21 U.S. Code 2223)
    Methodological Approach to Developing a Risk-Ranking Model for Food Tracing FSMA Section 204 (21 U.S. Code § 2223) Center for Food Safety and Applied Nutrition Food and Drug Administration U.S. Department of Health and Human Services August 2020 Contributors RRM-FT Development Team Yuhuan Chen, PhD (lead) Sofia Santillana Farakos, PhD (deputy lead) Régis Pouillot, PhD (model implementation) Aurelie Pohl, PhD (subject matter expert) Lori Papadakis (coordinated external peer reviews) Judith Spungen, MS (subject matter expert, consumption) RRM-FT Project Advisors Jane Van Doren, PhD Sherri Dennis, PhD RRM-FT Project Advisory Group #Previously University of Florida; *PAG member during earlier stage of development or retired. Acknowledgements FDA developed the Risk-Ranking Model for Food Tracing (RRM-FT) with technical assistance from RTI International and the Institute of Food Technologists, including conducting several external expert elicitations. We thank members of the external expert panels, members of the FDA project advisory group, and the many FDA CFSAN subject matter experts who provided invaluable knowledge and expertise, especially André Markon, Andrew Yeung, Alexandra Gavelek, Angela Alexander, Bhavini Patel, Brett Podoski, Cecile Punzalan, Cecilia Crowley, 2 Cerisé Hardy, Dana Hoffman-Pennesi, Daria Kleinmeier, David Ingram, David Oryang, Diane Gubernot, Donald Kautter, Elizabeth Noelia Williams, Fazila Shakir, Gerardo Ramirez, Girvin Liggans, Glenda Lewis, Guy Skinner, Hao Pang, Insook Son, Jane Cluster, John Sheehan, Karen Swajian, Kari Irvin, Kathleen D'Ovidio, Kevin Smith, Lauren Robin, Laurie Bucher, Leslie Smoot, Lisa Ross, Mary Tijerina, Mehran Niazi, Michael Mahovic, Michael Mignogna, Michelle Trachy, Monica Metz, Nancy Bufano, Nichole Nolan, Obianuju Nsofor, Olivia Dominic, Paul South, Pete Koufopoulos, Quynh-Anh Nguyen, Richard Podolak, Samir Assar, Sarah Winfield, Steven Bloodgood, and Tami Cloyd.
    [Show full text]
  • Ochratoxin A: General Overview and Actual Molecular Status
    Toxins 2010, 2, 461-493; doi:10.3390/toxins2040461 OPEN ACCESS toxins ISSN 2072-6651 www.mdpi.com/journal/toxins Review Ochratoxin A: General Overview and Actual Molecular Status André el Khoury 1 and Ali Atoui 2,* 1 Centre d’analyses et de recherches, Faculté des Sciences, Université Saint-Joseph, Beyrouth, Lebanon 2 Lebanese Atomic Energy Commission-CNRS, P.O. Box 11-8281, Riad El Solh, 1107 2260 Beirut, Lebanon * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: 00961 (1) 450 811; Fax: 00961 (1) 450 810. Received: 24 January 2010; in revised form: 5 March 2010 / Accepted: 8 March 2010 / Published: 29 March 2010 Abstract: Ochratoxin A (OTA) is a mycotoxin produced by several species of Aspergillus and Penicillium fungi that structurally consists of a para-chlorophenolic group containing a dihydroisocoumarin moiety that is amide-linked to L-phenylalanine. OTA is detected worldwide in various food and feed sources. Studies show that this molecule can have several toxicological effects such as nephrotoxic, hepatotoxic, neurotoxic, teratogenic and immunotoxic. A role in the etiology of Balkan endemic nephropathy and its association to urinary tract tumors has been also proved. In this review, we will explore the general aspect of OTA: physico-chemical properties, toxicological profile, OTA producing fungi, contaminated food, regulation, legislation and analytical methods. Due to lack of sufficient information related to the molecular background, this paper will discuss in detail the recent advances in molecular biology of OTA biosynthesis, based on information and on new data about identification and characterization of ochratoxin biosynthetic genes in both Penicillium and Aspergillus species.
    [Show full text]
  • Occurrence of Deoxynivalenol and Ochratoxin a in Beers and Wines Commercialized in Paraguay
    toxins Communication Occurrence of Deoxynivalenol and Ochratoxin A in Beers and Wines Commercialized in Paraguay Andrea Alejandra Arrúa 1,2,* , Juliana Moura Mendes 1 , Pablo Arrúa 1, Francisco Paulo Ferreira 1,2 , Gabriela Caballero 1, Cinthia Cazal 1,2, Man Mohan Kohli 3, Inocencia Peralta 1, Gabriela Ulke 2 and Danilo Fernández Ríos 2,* 1 Dirección General de Investigación Científica y Tecnológica, Centro Multidisciplinario de Investigaciones Tecnológicas, Universidad Nacional de Asunción, San Lorenzo 1039, Paraguay; [email protected] (J.M.M.); [email protected] (P.A.); [email protected] (F.P.F.); [email protected] (G.C.); [email protected] (C.C.); [email protected] (I.P.) 2 Facultad de Ciencias Exactas y Naturales, Departamento de Biotecnología, Universidad Nacional de Asunción, San Lorenzo 1039, Paraguay; [email protected] 3 CámaraParaguaya de Exportadores y Comercializadores de Cereales y Oleaginosas, Asunción 1548, Paraguay; [email protected] * Correspondence: [email protected] (A.A.A.); [email protected] (D.F.R.); Tel.: +5-952-158-5600 (A.A.A.) Received: 29 April 2019; Accepted: 25 May 2019; Published: 30 May 2019 Abstract: Alcoholic beverages can be contaminated with mycotoxins. Ochratoxin A (OTA) is the most frequently detected mycotoxinin wine and is produced by several species of Aspergillus. This mycotoxin is nephrotoxic and carcinogenic. In beer, the most commonly identified mycotoxin is deoxynivalenol (DON). Ingestion of food contaminated with DON has been associated with adverse gastrointestinal effects. Despite the harmful effects of mycotoxins on health, there are no regulations regarding their limits in alcoholic beverages in Paraguay. Here we determine the presence of OTA and DON in wine and beer, respectively.
    [Show full text]